|
1
|
Fatal inhalational anthrax in a 94-year-old Connecticut woman.
|
JAMA
|
2002
|
3.26
|
|
2
|
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
|
Emerg Infect Dis
|
2002
|
2.76
|
|
3
|
Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.
|
J Infect Dis
|
2004
|
2.29
|
|
4
|
Pathology and pathogenesis of bioterrorism-related inhalational anthrax.
|
Am J Pathol
|
2003
|
2.11
|
|
5
|
Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins.
|
Infect Immun
|
2005
|
2.05
|
|
6
|
Cationic antimicrobial peptide resistance in Neisseria meningitidis.
|
J Bacteriol
|
2005
|
1.99
|
|
7
|
Comparative genomics of Neisseria meningitidis: core genome, islands of horizontal transfer and pathogen-specific genes.
|
Microbiology
|
2006
|
1.75
|
|
8
|
Genetic basis for nongroupable Neisseria meningitidis.
|
J Infect Dis
|
2003
|
1.62
|
|
9
|
Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
|
Clin Infect Dis
|
2008
|
1.60
|
|
10
|
Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway.
|
Infect Immun
|
2004
|
1.59
|
|
11
|
A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor.
|
Clin Infect Dis
|
2007
|
1.51
|
|
12
|
Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
|
Vaccine
|
2007
|
1.49
|
|
13
|
Meningococcal disease: changes in epidemiology and prevention.
|
Clin Epidemiol
|
2012
|
1.48
|
|
14
|
Description and nomenclature of Neisseria meningitidis capsule locus.
|
Emerg Infect Dis
|
2013
|
1.47
|
|
15
|
Assessing the risk of laboratory-acquired meningococcal disease.
|
J Clin Microbiol
|
2005
|
1.47
|
|
16
|
sodC-based real-time PCR for detection of Neisseria meningitidis.
|
PLoS One
|
2011
|
1.45
|
|
17
|
Anthrax lethal toxin paralyzes neutrophil actin-based motility.
|
J Infect Dis
|
2005
|
1.32
|
|
18
|
Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum.
|
Infect Immun
|
2008
|
1.32
|
|
19
|
Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
|
J Infect Dis
|
2010
|
1.31
|
|
20
|
KpsF is the arabinose-5-phosphate isomerase required for 3-deoxy-D-manno-octulosonic acid biosynthesis and for both lipooligosaccharide assembly and capsular polysaccharide expression in Neisseria meningitidis.
|
J Biol Chem
|
2002
|
1.24
|
|
21
|
Endotoxin of Neisseria meningitidis composed only of intact lipid A: inactivation of the meningococcal 3-deoxy-D-manno-octulosonic acid transferase.
|
J Bacteriol
|
2002
|
1.22
|
|
22
|
Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible.
|
Antimicrob Agents Chemother
|
2005
|
1.22
|
|
23
|
Neisseria meningitidis: biology, microbiology, and epidemiology.
|
Methods Mol Biol
|
2012
|
1.20
|
|
24
|
Translocation and surface expression of lipidated serogroup B capsular Polysaccharide in Neisseria meningitidis.
|
Infect Immun
|
2005
|
1.19
|
|
25
|
Management of anthrax meningitis.
|
Lancet Infect Dis
|
2005
|
1.17
|
|
26
|
Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease.
|
J Infect Dis
|
2002
|
1.16
|
|
27
|
Paclitaxel binding to human and murine MD-2.
|
J Biol Chem
|
2008
|
1.13
|
|
28
|
Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages.
|
Cell Microbiol
|
2005
|
1.08
|
|
29
|
Phase variable changes in genes lgtA and lgtC within the lgtABCDE operon of Neisseria gonorrhoeae can modulate gonococcal susceptibility to normal human serum.
|
J Endotoxin Res
|
2002
|
1.08
|
|
30
|
Biofilm formation by Neisseria meningitidis.
|
Infect Immun
|
2004
|
1.05
|
|
31
|
Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax.
|
Emerg Infect Dis
|
2002
|
1.04
|
|
32
|
The MisR/MisS two-component regulatory system influences inner core structure and immunotype of lipooligosaccharide in Neisseria meningitidis.
|
J Biol Chem
|
2004
|
1.04
|
|
33
|
Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays.
|
Am J Clin Pathol
|
2004
|
1.04
|
|
34
|
Autoregulation of the MisR/MisS two-component signal transduction system in Neisseria meningitidis.
|
J Bacteriol
|
2006
|
1.03
|
|
35
|
Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells.
|
Infect Immun
|
2008
|
0.99
|
|
36
|
O-Acetylation of the terminal N-acetylglucosamine of the lipooligosaccharide inner core in Neisseria meningitidis. Influence on inner core structure and assembly.
|
J Biol Chem
|
2006
|
0.98
|
|
37
|
Hexa-acylation and KDO(2)-glycosylation determine the specific immunostimulatory activity of Neisseria meningitidis lipid A for human monocyte derived dendritic cells.
|
Vaccine
|
2005
|
0.98
|
|
38
|
MisR/MisS two-component regulon in Neisseria meningitidis.
|
Infect Immun
|
2007
|
0.97
|
|
39
|
Impact of bioterrorism preparedness on the public health response to the 2003-2004 influenza vaccine crisis.
|
Public Health Rep
|
2005
|
0.96
|
|
40
|
The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase.
|
J Biol Chem
|
2004
|
0.96
|
|
41
|
Genetic basis for biosynthesis of the (alpha 1-->4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X.
|
Infect Immun
|
2003
|
0.95
|
|
42
|
Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes.
|
Glycobiology
|
2004
|
0.95
|
|
43
|
Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis.
|
Infect Immun
|
2006
|
0.95
|
|
44
|
TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A.
|
Vaccine
|
2007
|
0.95
|
|
45
|
Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4.
|
Glycobiology
|
2007
|
0.94
|
|
46
|
Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae.
|
Antimicrob Agents Chemother
|
2010
|
0.94
|
|
47
|
Increase in pilus islet 2-encoded pili among Streptococcus pneumoniae isolates, Atlanta, Georgia, USA.
|
Emerg Infect Dis
|
2010
|
0.93
|
|
48
|
Meningococcal conjugate vaccines.
|
Expert Opin Pharmacother
|
2004
|
0.92
|
|
49
|
Development and evaluation of an improved mouse model of meningococcal colonization.
|
Infect Immun
|
2003
|
0.91
|
|
50
|
Acquired inducible antimicrobial resistance in Gram-positive bacteria.
|
Future Microbiol
|
2012
|
0.89
|
|
51
|
Mitis group streptococci express variable pilus islet 2 pili.
|
PLoS One
|
2011
|
0.88
|
|
52
|
Notes from the Field: Increase in Neisseria meningitidis-Associated Urethritis Among Men at Two Sentinel Clinics - Columbus, Ohio, and Oakland County, Michigan, 2015.
|
MMWR Morb Mortal Wkly Rep
|
2016
|
0.88
|
|
53
|
The human host defense peptide LL-37 interacts with Neisseria meningitidis capsular polysaccharides and inhibits inflammatory mediators release.
|
PLoS One
|
2010
|
0.87
|
|
54
|
Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj.
|
J Infect Dis
|
2004
|
0.86
|
|
55
|
Attachment and invasion of Neisseria meningitidis to host cells is related to surface hydrophobicity, bacterial cell size and capsule.
|
PLoS One
|
2013
|
0.86
|
|
56
|
In vivo determination of Neisseria meningitidis serogroup A capsular polysaccharide by whole cell high-resolution magic angle spinning NMR spectroscopy.
|
Carbohydr Res
|
2006
|
0.86
|
|
57
|
Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.
|
Vaccine
|
2011
|
0.85
|
|
58
|
The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491.
|
Carbohydr Res
|
2008
|
0.85
|
|
59
|
Vaccines for the unvaccinated: protecting the herd.
|
J Infect Dis
|
2008
|
0.83
|
|
60
|
Serogroup B meningococcal vaccines.
|
Curr Opin Investig Drugs
|
2006
|
0.83
|
|
61
|
Requirement of NMB0065 for connecting assembly and export of sialic acid capsular polysaccharides in Neisseria meningitidis.
|
Microbes Infect
|
2010
|
0.82
|
|
62
|
Virulence factors of gram-negative bacteria in sepsis with a focus on Neisseria meningitidis.
|
Contrib Microbiol
|
2011
|
0.81
|
|
63
|
Induction of efflux-mediated macrolide resistance in Streptococcus pneumoniae.
|
Antimicrob Agents Chemother
|
2011
|
0.81
|
|
64
|
Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium.
|
Clin Transl Sci
|
2013
|
0.80
|
|
65
|
Laboratory-acquired serogroup A meningococcal meningitis.
|
J Occup Health
|
2007
|
0.79
|
|
66
|
Physicochemical characterization and biological activity of lipooligosaccharides and lipid A from Neisseria meningitidis.
|
J Endotoxin Res
|
2007
|
0.79
|
|
67
|
Industry-related outbreak of human anthrax.
|
Emerg Infect Dis
|
2003
|
0.79
|
|
68
|
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
|
Vaccine
|
2007
|
0.78
|
|
69
|
Pilus backbone protein PitB of Streptococcus pneumoniae contains stabilizing intramolecular isopeptide bonds.
|
Biochem Biophys Res Commun
|
2011
|
0.76
|
|
70
|
Preventing influenza: vaccine systems and practices in the Southeast.
|
Public Health Rep
|
2007
|
0.75
|
|
71
|
Adjuvant therapy for meningococcal sepsis.
|
Pediatr Infect Dis J
|
2005
|
0.75
|
|
72
|
West Nile virus southeast conference.
|
Emerg Infect Dis
|
2003
|
0.75
|